Artificial intelligence in medicine : mitigating risks and maximizing benefits via quality assurance, quality control, and acceptance testing
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Institute of Radiology..
The adoption of artificial intelligence (AI) tools in medicine poses challenges to existing clinical workflows. This commentary discusses the necessity of context-specific quality assurance (QA), emphasizing the need for robust QA measures with quality control (QC) procedures that encompass (1) acceptance testing (AT) before clinical use, (2) continuous QC monitoring, and (3) adequate user training. The discussion also covers essential components of AT and QA, illustrated with real-world examples. We also highlight what we see as the shared responsibility of manufacturers or vendors, regulators, healthcare systems, medical physicists, and clinicians to enact appropriate testing and oversight to ensure a safe and equitable transformation of medicine through AI.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1 |
|---|---|
| Enthalten in: |
BJR artificial intelligence - 1(2024), 1 vom: 14. Jan., Seite ubae003 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mahmood, Usman [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acceptance testing |
|---|
| Anmerkungen: |
Date Revised 06.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/bjrai/ubae003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369666712 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369666712 | ||
| 003 | DE-627 | ||
| 005 | 20240406232300.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240313s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/bjrai/ubae003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1367.xml |
| 035 | |a (DE-627)NLM369666712 | ||
| 035 | |a (NLM)38476957 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mahmood, Usman |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Artificial intelligence in medicine |b mitigating risks and maximizing benefits via quality assurance, quality control, and acceptance testing |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of the British Institute of Radiology. | ||
| 520 | |a The adoption of artificial intelligence (AI) tools in medicine poses challenges to existing clinical workflows. This commentary discusses the necessity of context-specific quality assurance (QA), emphasizing the need for robust QA measures with quality control (QC) procedures that encompass (1) acceptance testing (AT) before clinical use, (2) continuous QC monitoring, and (3) adequate user training. The discussion also covers essential components of AT and QA, illustrated with real-world examples. We also highlight what we see as the shared responsibility of manufacturers or vendors, regulators, healthcare systems, medical physicists, and clinicians to enact appropriate testing and oversight to ensure a safe and equitable transformation of medicine through AI | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a acceptance testing | |
| 650 | 4 | |a artificial intelligence | |
| 650 | 4 | |a deep learning | |
| 650 | 4 | |a machine learning | |
| 650 | 4 | |a quality assurance | |
| 650 | 4 | |a quality control | |
| 650 | 4 | |a radiology | |
| 700 | 1 | |a Shukla-Dave, Amita |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Heang-Ping |e verfasserin |4 aut | |
| 700 | 1 | |a Drukker, Karen |e verfasserin |4 aut | |
| 700 | 1 | |a Samala, Ravi K |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Quan |e verfasserin |4 aut | |
| 700 | 1 | |a Vergara, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Greenspan, Hayit |e verfasserin |4 aut | |
| 700 | 1 | |a Petrick, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Sahiner, Berkman |e verfasserin |4 aut | |
| 700 | 1 | |a Huo, Zhimin |e verfasserin |4 aut | |
| 700 | 1 | |a Summers, Ronald M |e verfasserin |4 aut | |
| 700 | 1 | |a Cha, Kenny H |e verfasserin |4 aut | |
| 700 | 1 | |a Tourassi, Georgia |e verfasserin |4 aut | |
| 700 | 1 | |a Deserno, Thomas M |e verfasserin |4 aut | |
| 700 | 1 | |a Grizzard, Kevin T |e verfasserin |4 aut | |
| 700 | 1 | |a Näppi, Janne J |e verfasserin |4 aut | |
| 700 | 1 | |a Yoshida, Hiroyuki |e verfasserin |4 aut | |
| 700 | 1 | |a Regge, Daniele |e verfasserin |4 aut | |
| 700 | 1 | |a Mazurchuk, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Suzuki, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Morra, Lia |e verfasserin |4 aut | |
| 700 | 1 | |a Huisman, Henkjan |e verfasserin |4 aut | |
| 700 | 1 | |a Armato, Samuel G |c 3rd |e verfasserin |4 aut | |
| 700 | 1 | |a Hadjiiski, Lubomir |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BJR artificial intelligence |d 2024 |g 1(2024), 1 vom: 14. Jan., Seite ubae003 |w (DE-627)NLM369666690 |x 2976-8705 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:2024 |g number:1 |g day:14 |g month:01 |g pages:ubae003 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/bjrai/ubae003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 2024 |e 1 |b 14 |c 01 |h ubae003 | ||